CCI
PFE icon

Columbus Circle Investors’s Pfizer PFE Stock Holding History

Columbus Circle Investors’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-274,308
Closed -$9.16M – 294
2016
Q2 		$9.16M Sell
274,308
-303,269
-53% -$9.68M 0.09% 175
2016
Q1 		$16.2M Sell
577,577
-315,869
-35% -$9.02M 0.14% 134
2015
Q4 		$27.4M Buy
893,446
+737,324
+472% +$23.2M 0.22% 105
2015
Q3 		$4.65M Buy
+156,122
New +$5.01M 0.04% 226
2014
Q2 		– Sell
-7,544,686
Closed -$230M – 296
2014
Q1 		$230M Buy
7,544,686
+1,374,896
+22% +$41M 1.53% 13
2013
Q4 		$179M Sell
6,169,790
-161,944
-3% -$4.71M 1.23% 14
2013
Q3 		$173M Buy
6,331,734
+48,768
+0.8% +$1.33M 1.22% 16
2013
Q2 		$167M Buy
+6,282,966
New +$174M 1.34% 15

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Columbus Circle Investors's PFE Position: Q3 2016 in Review

Columbus Circle Investors sold out of Pfizer (PFE) in Q3 2016, closing a stake of 274,308 shares — an estimated $9.16M sold.

Columbus Circle Investors first reported a position in PFE in Q2 2013 and held it in 8 quarters. The position peaked at $230M in Q1 2014. 1,962 funds tracked by Wall St. Rank hold PFE as of Q3 2016.

  • Columbus Circle Investors reported no remaining Pfizer position as of Q3 2016 after selling out during the quarter.
  • Columbus Circle Investors sold 274,308 Pfizer shares in Q3 2016, an estimated $9.16M.
  • Columbus Circle Investors first reported a position in Pfizer in Q2 2013 and held it in 8 quarters.
  • Columbus Circle Investors's Pfizer position peaked at $230M in Q1 2014.
  • 1,962 funds tracked by Wall St. Rank held Pfizer as of Q3 2016.

Based on Columbus Circle Investors's 13F filing for Q3 2016, filed 10 Nov 2016.